Stocks monitoring (September 10, 2020)
Fastly and Google Cloud
Under a single billing arrangement and using Google Cloud committed spend, Google Cloud customers can now purchase Fastly – the first partner edge cloud-based content delivery solution to be offered within the Google Cloud Marketplace – as a part of their modern tech stack.
Grail IPO
Ophir Gottlieb on Grail IPO on Twitter:
- Looks like a strong competitor to NVTA.
- GRAIL is poised to detect cancer early by combining high-intensity sequencing of unprecedented depth with the techniques of modern data science. Genomic medicine, GRAIL is creating vast datasets to develop evidence supporting our products
Bill Gates and Jeff Bezos-backed cancer detection company Grail, led by ex-Juno CEO, files for IPO.
- Bill Gates and Jeff Bezos-backed cancer detection company Grail, led by ex-Juno CEO, files for IPO
- Grail does not have revenue or a commercially-available product. That reflects the traditional life cycle of biotech companies, which commonly invest in research and development for years before bringing products to market. It reported a $136.4 million loss in the first half of this year, up from $117.2 million a year ago.
- In its IPO filing, Grail said its multi-cancer early detection test, Galleri, will commercially launch in 2021 as a laboratory-developed test. It said the test “can lead to a dramatic increase in early cancer diagnosis.”